Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis

References

1. ↵
   Robinson WH, Genovese MC, and Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism. Arthritis Rheum 2001;44:1977–1983

   CrossRefPubMedWeb of Science
2. ↵
   Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141–147

   CrossRefPubMedWeb of Science
3. ↵
   Targan SR, Hanauer SR, van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 1997;337:1029–1035

   CrossRefPubMedWeb of Science
4. ↵
   Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001;44:2862–2869

   CrossRefPubMedWeb of Science
5. ↵
   Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002;120:985–987

   PubMedWeb of Science
6. ↵
   Van Oosten BW, Barkof F, Truyen L, et al. Increased MRI activity andimmune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996;47:1531–1534

   Abstract/FREE Full Text
7. ↵
   The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. TNF neutralization in multiple sclerosis: results of a randomized, placebo-controlled multicenter study. Neurology 1999;53:457–465

   Abstract/FREE Full Text
8. ↵
   Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001;57:1885–1888

   Abstract/FREE Full Text
9. ↵
   Mohan N, Cupps TR. Reply to the editor. Arthritis Rheum 2002;46:3108–3109
10. ↵
    Bekkelund SI, Pierre-Jerome C, Husby G, Mellgren SI. Quantitative cerebral MR in rheumatoid arthritis. AJNR Am J Neuroradiol 1995;16:767–772

    Abstract
11. ↵
    Selmaj K. Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system [Suppl]. Ann Rheum Dis 2000;59:i94–i102

    FREE Full Text